IRIS
PIRTOLI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.095
EU - Europa 5.977
AS - Asia 1.080
OC - Oceania 14
AF - Africa 12
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.075
GB - Regno Unito 1.950
IE - Irlanda 1.023
CN - Cina 752
UA - Ucraina 629
SE - Svezia 546
IT - Italia 541
DE - Germania 373
FR - Francia 294
RU - Federazione Russa 294
FI - Finlandia 157
SG - Singapore 128
ES - Italia 71
TR - Turchia 50
IN - India 39
VN - Vietnam 38
BE - Belgio 24
IR - Iran 19
AU - Australia 14
IM - Isola di Man 14
JP - Giappone 13
CA - Canada 12
NL - Olanda 12
DK - Danimarca 11
BR - Brasile 7
CI - Costa d'Avorio 7
EU - Europa 7
PL - Polonia 7
MX - Messico 6
PH - Filippine 6
HK - Hong Kong 5
MY - Malesia 5
CZ - Repubblica Ceca 4
NO - Norvegia 4
OM - Oman 4
AT - Austria 3
CH - Svizzera 3
KR - Corea 3
RS - Serbia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CL - Cile 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
IQ - Iraq 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.198
Salva come PNG Salva come JPEG
Città #
Southend 1.774
Dublin 1.004
Fairfield 841
Chandler 617
Jacksonville 485
Ashburn 484
Woodbridge 403
Wilmington 371
Seattle 305
Ann Arbor 300
Houston 298
Cambridge 249
Princeton 197
Siena 181
Nanjing 173
Beijing 171
Menlo Park 144
New York 120
Fremont 108
San Mateo 94
Singapore 80
Dearborn 76
Helsinki 75
Málaga 70
Boardman 68
Shenyang 50
Izmir 47
Nanchang 46
San Diego 44
Shanghai 42
Florence 41
Dong Ket 37
Moscow 33
Tianjin 33
Kunming 30
Milan 29
Lancaster 26
Munich 25
Brussels 24
Hebei 24
Zhengzhou 21
Changsha 19
Jinan 19
Jiaxing 18
Venezia 17
Redwood City 16
Rome 16
Douglas 14
London 14
Falls Church 13
Hangzhou 13
Los Angeles 13
Ningbo 13
Norwalk 11
Bari 10
Bologna 10
Düsseldorf 10
Guangzhou 10
San Francisco 9
Santa Clara 9
Zanjan 9
Copenhagen 8
Fuzhou 8
Hefei 8
Lanzhou 8
Phoenix 8
Abidjan 7
Auburn Hills 7
Changchun 7
Kilburn 7
Musashino 7
Osnabrück 7
Taizhou 6
Washington 6
Dallas 5
Fort Worth 5
Hounslow 5
Indiana 5
Toronto 5
Delhi 4
Islington 4
Oslo 4
Reggio Calabria 4
Renton 4
Sacramento 4
Sydney 4
Turin 4
Venice 4
Warsaw 4
Arezzo 3
Brno 3
Canberra 3
Central 3
Edinburgh 3
Enniskerry 3
Falkenstein 3
Gavirate 3
Henderson 3
Iligan 3
Kragujevac 3
Totale 9.695
Salva come PNG Salva come JPEG
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 247
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 241
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 229
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 228
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. 225
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 215
microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to Temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. 213
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 209
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 199
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 183
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases. 180
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 179
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 172
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 170
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 166
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 165
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma 158
Emerging roles of microRNA in modulating cell-death processes in malignant glioma 157
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 157
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 155
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells 155
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 153
Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma 152
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 150
Lymphoepithelioma-like carcinoma of the endometrium 148
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 148
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 147
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 147
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 147
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 145
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 143
AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells 141
Carcinoma with eccrine differentiation arising in a seborrhoeic keratosis. 141
null 139
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 138
Beta-catenin and Gli1 are prognostic markers in glioblastoma 135
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO). 134
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 132
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 130
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 130
null 130
The prognostic role of Beclin 1 protein expression in high-grade gliomas 127
null 126
Three-dimensional conformal radiotherapy, temozolomide chemotherapy and high-dose fractionated stereotactic boost in a protocol driven, post-operative treatment schedule for high-grade gliomas. 123
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology) 122
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 122
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 121
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 118
In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, Mib1, and topoisomerase IIα protein expression. 117
null 117
null 116
MR Volumetry of Rectal Cancer: DWI versus T2-weighted data sets. 115
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 114
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer 114
Spindle cell lipoma of the orbit: a case report of an unusual orbital pathology 112
Tumori tiroidei 111
Restaging patients with N2 non-small cell lung cancer after neoadjuvant therapy: TCMS accuracy using a multi-criteria approach 111
Benign lymphoepithelial lesion associated with squamous cell carcinoma of the skin: an immunohistochemical and molecular genetic study 110
null 107
NEOPLASIE CEREBRALI, LINEE GUIDA AIOM. 105
Neoplasie di encefalo, occhio-orbita, ipofisi e midollo spinale 104
Surrenalectomia medica con aminoglutetimide nel carcinoma mammario in fase avanzata 103
Adjuvant radiotherapy after radical prostatectomy: multinstitutional experience 101
Unresectable retroperitoneal malignant fibrous histiocytoma: Prolonged complete remission following chemoradiotherapy 101
null 100
Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report [La volumetria con risonanza magnetica pesata in diffusione nella valutazione della risposta alla chemio-radioterapia nel tumore del retto: studio preliminare] 98
Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori della tiroide dell’epitelio follicolare. 97
Risultati terapeutici nel carcinoma mammario sottoposto a trattamento conservative basato sulla radioterapia. Lo standard di cura nel sud-est della Toscana negli anni 1996-2000 96
Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines 95
null 95
Neoplasie della sfera Otorinolaringoiatrica 95
null 95
Impact of timing of radiotherapy after conservative breast surgery on local control and metastases in pTis-T1-T2 N0 patients.Tuscany and Umbria Radiotherapy Departments experience. 94
Beta-catenin and Gli1 are important prognostic factors in glioblastoma: combination with p53, EGFR and Mib1 markers to predict long term survival (paper #1628) 94
The role of Radiation Oncologist in the management of antineoplastic drugs in Italy 92
null 92
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 92
Associazione Epirubicina e Vincristina (Ev) nel trattamento del carcinoma mammario metastatico. Risultati preliminari 91
Chirurgia conservativa e radioterapia a dosi "moderate" nel carcinoma mammario in fase iniziale. 90
null 89
Prophylactic whole brain irradiation after complete response to primary treatment in limited stage small cell lung cancer: the experience of four radiotherapy units in Tuscany. 88
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 87
Updating the role of radiotherapy in the management of epithelial ovarian cancer 87
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes. 86
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 86
Primary neuroendocrine (Merkel cell) carcinoma of the eyelid in a young woman - Report of a Case 84
Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques [La radioterapia dei gliomi maligni. I risultati delle modalità tradizionali di trattamento e le prospettive delle tecniche avanzate] 84
null 83
La radioterapia oncologica 82
null 82
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in twelve italian radiation oncology centers 81
Restaging brain computerized tomography after treatment of non-operable lung neoplasms [La Tomografia Computerizzata dell'encefalo nella ristadiazione dopo terapia delle neoplasie polmonari non suscettibili di trattamento chirurgico] 80
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 77
Cytoplasmatic expression of the Beclin 1 autophagy protein gene product in a sereis of malignant glioma patients undergoing radio- and chemotherapy: a preliminary report. 77
Conservative surgery and radiotherapy for ductal carcinoma of the breast. A retrospective analysis of 141 patients 76
The Istituto Toscano Tumori (ITT) and the radiotherapy Centers. 75
The Activity Based Costing (ABC) evaluation in radiotherapy: a comparison between 3D-CRT, IMRT and IGRT. 75
Intelligent radiation 73
null 70
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial 69
Totale 12.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.245 0 0 197 380 144 232 231 365 222 243 77 154
2020/20212.156 93 267 49 210 113 347 72 297 199 202 123 184
2021/20221.355 100 149 132 97 69 54 58 73 70 141 118 294
2022/20232.066 114 162 291 292 200 401 34 177 197 86 65 47
2023/20241.679 59 38 139 85 61 451 622 59 9 52 22 82
2024/2025515 92 146 277 0 0 0 0 0 0 0 0 0
Totale 13.437